Your browser doesn't support javascript.
loading
Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?
Schwab, Claire; Nebral, Karin; Chilton, Lucy; Leschi, Cristina; Waanders, Esmé; Boer, Judith M; Zaliová, Markéta; Sutton, Rosemary; Öfverholm, Ingegerd Ivanov; Ohki, Kentaro; Yamashita, Yuka; Groeneveld-Krentz, Stefanie; Fronková, Eva; Bakkus, Marleen; Tchinda, Joelle; Barbosa, Thayana da Conceição; Fazio, Grazia; Mlynarski, Wojciech; Pastorczak, Agata; Cazzaniga, Giovanni; Pombo-de-Oliveira, Maria S; Trka, Jan; Kirschner-Schwabe, Renate; Imamura, Toshihiko; Barbany, Gisela; Stanulla, Martin; Attarbaschi, Andishe; Panzer-Grümayer, Renate; Kuiper, Roland P; den Boer, Monique L; Cavé, Hélène; Moorman, Anthony V; Harrison, Christine J; Strehl, Sabine.
Afiliação
  • Schwab C; Leukaemia Research Cytogenetics Group, Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Nebral K; Children's Cancer Research Institute, St Anna Kinderkrebsforschung, Vienna, Austria.
  • Chilton L; Leukaemia Research Cytogenetics Group, Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Leschi C; INSERM Unité Mixte de Recherché 1131, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris Sorbonne Cité, Paris, France.
  • Waanders E; Département de Génétique, Hôpital Robert Debré, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Boer JM; Department of Human Genetics, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
  • Zaliová M; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Sutton R; Department of Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Öfverholm II; Childhood Leukaemia Investigation Prague, Department of Pediatric Hematology/Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
  • Ohki K; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia.
  • Yamashita Y; Clinical Genetics Section, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Groeneveld-Krentz S; Department of Pediatric Hematology and Oncology, National Center for Child Health and Development, Tokyo, Japan.
  • Fronková E; Clinical Research Center, Nagoya Medical Center, National Hospital Organization, Aichi, Japan.
  • Bakkus M; Division of Oncology and Hematology, Department of Pediatrics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Tchinda J; Childhood Leukaemia Investigation Prague, Department of Pediatric Hematology/Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
  • Barbosa TDC; Department of Hematology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium.
  • Fazio G; Pediatric Oncology, Children's Research Centre, University Children's Hospital Zürich, Zürich, Switzerland.
  • Mlynarski W; Pediatric Hematology-Oncology Program, Research Center, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
  • Pastorczak A; Centro Ricerca Tettamanti, Clinica Pediatrica, Università di Milano-Bicocca, Monza, Italy.
  • Cazzaniga G; Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Lodz, Poland.
  • Pombo-de-Oliveira MS; Department of Pediatrics, Oncology, Hematology and Diabetology, Medical University of Lodz, Lodz, Poland.
  • Trka J; Centro Ricerca Tettamanti, Clinica Pediatrica, Università di Milano-Bicocca, Monza, Italy.
  • Kirschner-Schwabe R; Pediatric Hematology-Oncology Program, Research Center, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
  • Imamura T; Childhood Leukaemia Investigation Prague, Department of Pediatric Hematology/Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
  • Barbany G; Division of Oncology and Hematology, Department of Pediatrics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Stanulla M; German Cancer Consortium and German Cancer Research Center, Heidelberg, Germany.
  • Attarbaschi A; Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Panzer-Grümayer R; Clinical Genetics Section, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Kuiper RP; Department of Pediatric Hematology and Oncology, Medical School Hannover, Hannover, Germany.
  • den Boer ML; Department of Pediatric Hematology and Oncology, St Anna Children's Hospital, Medical University of Vienna, Austria; and.
  • Cavé H; Children's Cancer Research Institute, St Anna Kinderkrebsforschung, Vienna, Austria.
  • Moorman AV; Department of Human Genetics, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
  • Harrison CJ; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Strehl S; Dutch Childhood Oncology Group, The Hague, The Netherlands.
Blood Adv ; 1(19): 1473-1477, 2017 Aug 22.
Article em En | MEDLINE | ID: mdl-29296789
Intragenic PAX5 amplification defines a novel, relapse-prone subtype of B-cell precursor acute lymphoblastic leukemia with a poor outcome.
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Blood Adv Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Blood Adv Ano de publicação: 2017 Tipo de documento: Article